Mittleman Investment Management’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.12M Sell
201,975
-8,775
-4% -$96.2K 12.17% 4
2022
Q1
$2.29M Sell
210,750
-4,065
-2% -$53.6K 9.62% 3
2021
Q4
$2.91M Sell
214,815
-38,975
-15% -$520K 9.6% 3
2021
Q3
$3.44M Sell
253,790
-81,010
-24% -$1.15M 10.04% 3
2021
Q2
$4.78M Buy
334,800
+126,050
+60% +$1.82M 9.59% 3
2021
Q1
$2.92M Buy
+208,750
New +$3.4M 6.57% 5

Other funds holding VTRS

Mittleman Investment Management's VTRS Position: Q2 2022 in Review

Mittleman Investment Management reduced its Viatris (VTRS) stake by 4.2% in Q2 2022, selling an estimated $96.2K and leaving 201,975 shares worth $2.12M. The position accounts for 12.17% of the portfolio, ranked #4.

Mittleman Investment Management first reported a position in VTRS in Q1 2021 and has held it in 6 quarters since. The position peaked at $4.78M in Q2 2021. 1,011 funds tracked by Wall St. Rank hold VTRS as of Q2 2022.

  • Mittleman Investment Management held 201,975 shares of Viatris worth $2.12M as of Q2 2022.
  • Mittleman Investment Management sold 8,775 Viatris shares in Q2 2022, an estimated $96.2K.
  • Viatris made up 12.17% of Mittleman Investment Management's portfolio in Q2 2022, its #4 holding.
  • Mittleman Investment Management first reported a position in Viatris in Q1 2021 and has held it in 6 quarters since.
  • Mittleman Investment Management's Viatris position peaked at $4.78M in Q2 2021.
  • 1,011 funds tracked by Wall St. Rank held Viatris as of Q2 2022.

Based on Mittleman Investment Management's 13F filing for Q2 2022, filed 10 Aug 2022.